TITLE

Can PYY cure obesity?

AUTHOR(S)
Fields, Helen
PUB. DATE
September 2003
SOURCE
U.S. News & World Report;9/15/2003, Vol. 135 Issue 8, p49
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
States that PYY, which stands for Peptide YY[sub3-36], has potential for developing weight-loss drugs. How the hormone is made and travels to the brain indicate when to stop eating; Mention of research in Great Britain that suggests people eat less with PYY; Background on research into appetite hormones such as leptin; Outlook for a drug based on PYY to treat obesity.
ACCESSION #
10748044

 

Related Articles

  • COMMENTARY. Kahan, Scott; Cheskia, Lawrence j. // Evidence Based Medicine;Oct2008, Vol. 13 Issue 5, p137 

    The authors reflect on the study by Lally and colleagues on the effective means of losing weight. They acknowledged the tips on losing weight in the study but expressed that the content of the handout has ambiguities. They expect that follow up researches with greater extent of coverage...

  • Weight Management for Veterans: Examining Change in Weight Before and After MOVE! Dahn, Jason R.; Fitzpatrick, Stephanie L.; Llabre, Maria M.; Apterbach, Greta S.; Helms, Rebecca L.; Cugnetto, Marilyn L.; Klaus, Johanna; Florez, Hermes; Lawler, Tim // Obesity (19307381);May2011, Vol. 19 Issue 5, p977 

    In the year 2000, 31% of women and 40% of men receiving outpatient care at Veteran Affairs (VA) medical facilities were overweight (BMI ≥25 and <30 kg/m2); 37.4% of women and 32.9% of men were obese (BMI ≥30 kg/m2). The purpose of the present study was to assess treatment effects of...

  • Which Weight-Loss Programs Are Most Effective? Crawford-Faucher, Amy // American Family Physician;8/1/2012, Vol. 86 Issue 3, p280 

    The article presents a study on the effectiveness of commercial weight loss and weight management programs. The author mentions the obese patients in a primary care population who participate in select commercial weight-loss programs, experienced significant weight loss at one year. Meanwhile,...

  • Use of a Weight Loss Index for Evaluating Weight Management in Adults. Miller, Wayne C.; Henricson, Hilary L.; Moreland, Megan M. // Journal of Nutrition Education & Behavior;Jan/Feb2007, Vol. 39 Issue 1, p13 

    Objective: A quantitative method for evaluating weight loss using the body mass index (BMI) standard 25, during part or the entire weight loss continuum, was designed and tested. Design: Weight Loss Index (WLI) represents the area under tile curve of the graphical representation of the weight...

  • Intervening in the obesity epidemic. Aronne, Louis J.; Blackburn, George L.; Vash, Peter D. // Patient Care for the Nurse Practitioner;Aug2001, Vol. 4 Issue 8, p12 

    Discusses the dietary intervention needed for obese persons. Increase in the prevalence of obesity since 1991; Factors that contribute to excess weight; Categories of patients who are recommended to lose weight; Treatment selections based on body mass index; Recommended proportions of nutrient...

  • Long-term effects of an inpatient weight-loss program in obese children and the role of genetic predisposition-rationale and design of the LOGIC-trial.  // BMC Pediatrics;2012, Vol. 12 Issue 1, p30 

    The article offers information on the research conducted by authors related to the long-term effects of an inpatient weight-loss program in obese children and the role of genetics in it. It states that inpatient weight-loss programs have shown to be effective particularly regarding short-term...

  • Pharmacologic Approach to Obesity Management. Kushner, Robert F. // Journal of Family Practice;Dec2015 Supplement Hot Topics in Primary Care, pS37 

    The article presents a study which focuses on obesity management. Topics discussed include the role of lifestyle and medical intervention as an effective method for managing obese or overweight patients, the effectiveness of weight-loss medication in reducing calorie ingestion and in improving...

  • The future fight against fat.  // Prevention;Jun2007, Vol. 59 Issue 6, p36 

    This article discusses developments in appetite suppressants that would aid in weight loss. Compellis Pharmaceuticals has developed an appetite-suppressing nasal spray. Scientists at Imperial College London have developed an injectable compound containing pancreatic polypeptide, which triggers...

  • Waiting for the Perfect Weight-Loss Pill? Brown, Edwin W. // Medical Update;Mar99, Vol. 22 Issue 9, p2 

    Provides information on orlistat, a pill for overweight people. Benefits of the pill; How the pill works; Side-effects of the pill.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics